Programme
Study Unit 1
Why RCT (Randomised Controlled Trials)
Phases of clinical trials
Good Clinical Practice (GCP)Study Unit 3
Endpoints
Validity issuesStudy Unit 5
Power
Subgroup analysis (Multiplicity)
Interim analysis and stopping rules
Study Unit 2
Erroneous results
Types of RCT designs
Study Unit 4
Interpreting RCT results
NNT'sStudy Unit 6
Adaptive RCTs
Revision
Study Unit 1
Why RCT (Randomised Controlled Trials)
Phases of clinical trials
Good Clinical Practice (GCP)Study Unit 2
Erroneous results
Types of RCT designsStudy Unit 3
Endpoints
Validity issuesStudy Unit 4
Interpreting RCT results
NNT'sStudy Unit 5
Power
Subgroup analysis (Multiplicity)
Interim analysis and stopping rulesStudy Unit 6
Adaptive RCTs
Revision
Date
6 - 31 May 2024
15 Points
CPD accreditation
15 - 18 hours
Study time
Fees (excl VAT)
R3856 Corp Members
R4097 Stand Members
R4338 Ind Members
R4820 Non Members23 May 2024
Contact session
Meet the Contributor
Prof Danie van Zyl
Principal Specialist Physician and Adjunct Professor;
Head of Clinical Department, Department of Internal Medicine at Kalafong Provincial Tertiary Hospital;
Lecturer in Clinical Epidemiology
Click on image for bio
Scheduled Events
Please note that dates, topics and presenters are subject to change.
Latest Newsletter
Your information will be used as per the PTCMA Privacy Policy - by signing up for the PTCMA newsletter, you will receive monthly events updates, product notices and other PTCMA communication.